Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | JM Flexicap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹94.57 |
| 12 Apr 2015 | ₹164.55 |
| 31 May 2016 | ₹155.56 |
| 19 Jul 2017 | ₹224.59 |
| 07 Sep 2018 | ₹246.90 |
| 27 Oct 2019 | ₹265.89 |
| 15 Dec 2020 | ₹297.16 |
| 03 Feb 2022 | ₹413.46 |
| 25 Mar 2023 | ₹420.16 |
| 12 May 2024 | ₹729.93 |
| 01 Jul 2025 | ₹815.48 |
| 20 Aug 2026 | ₹841.04 |
| Metric | JM Financial · Direct NAV ₹116.72 Very High risk ★★★☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| +4.32% | +4.32% | |
| +17.00% | +14.11% | |
| +17.75% | +12.53% | |
| +16.81% | +13.78% | |
| +16.91% | +14.48% | |
| +15.78% | — | |
| +18.89% | +16.56% | |
| +17.99% | +15.80% | |
| +18.48% | +15.46% | |
| Risk | ||
| 15.80% | 14.19% | |
| 0.66 | 0.53 | |
| 0.89 | 0.73 | |
| -34.95% | -30.01% | |
| Nifty 500 | — | |
| +4.17% | +2.15% | |
| 1.04 | 0.97 | |
| 117.4% | 102.4% | |
| 101.8% | 90.2% | |
| 1.07% | 0.96% | |
| ₹5,032Cr | ₹4,325Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 21% | 34% | |
| Ruchi Fozdar | — | |
| 02 Jan 2013 | — | |
| 85 | — | |
| 29.5% | — | |
| 1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.